METTL14 has been identified as an oncogene in pancreatic cancer, as its depletion increases susceptibility to cisplatin-induced apoptosis in PANC-1 and CFPAC-1 cells (Kong et al., 2020). The gene discussed is METTL14; the disease is pancreatic neoplasm.